SLMAP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.180600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.746400E-01
Normal-vs-Stage2
4.856000E-01
Normal-vs-Stage3
5.911600E-01
Normal-vs-Stage4
1.781980E-01
Stage1-vs-Stage2
9.280400E-01
Stage1-vs-Stage3
2.794000E-01
Stage1-vs-Stage4
8.190200E-01
Stage2-vs-Stage3
2.875400E-01
Stage2-vs-Stage4
8.911800E-01
Stage3-vs-Stage4
8.279600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.426000E-01
Normal-vs-AfricanAmerican
2.867200E-01
Normal-vs-Asian
5.360600E-01
Caucasian-vs-AfricanAmerican
5.345400E-01
Caucasian-vs-Asian
7.776800E-01
AfricanAmerican-vs-Asian
7.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.518200E-01
Normal-vs-Female
5.773600E-01
Male-vs-Female
9.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.897000E-01
Normal-vs-Age(41-60Yrs)
2.744600E-01
Normal-vs-Age(61-80Yrs)
6.014400E-01
Normal-vs-Age(81-100Yrs)
5.645400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.396600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.639600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.656600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.430400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.152000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.666200E-01
Normal-vs-Daily Drinker
5.527200E-01
Normal-vs-Weekly Drinker
5.168200E-01
Normal-vs-Occasional Drinker
2.214400E-01
Normal-vs-Social Drinker
2.450200E-01
Non Drinker-vs-Daily Drinker
8.988200E-01
Non Drinker-vs-Weekly Drinker
4.634400E-01
Non Drinker-vs-Occasional Drinker
1.314970E-01
Non Drinker-vs-Social Drinker
3.740800E-01
Daily Drinker-vs-Weekly Drinker
5.214000E-01
Daily Drinker-vs-Occasional Drinker
2.667000E-01
Daily Drinker-vs-Social Drinker
3.938400E-01
Weekly Drinker-vs-Occasional Drinker
9.842000E-01
Weekly Drinker-vs-Social Drinker
6.091000E-01
Occasional Drinker-vs-Social Drinker
5.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.771200E-01
Normal-vs-Grade 2
1.595390E-01
Normal-vs-Grade 3
3.982000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.370800E-01
Grade 1-vs-Grade 3
5.850600E-01
Grade 1-vs-Grade 4
2.771200E-01
Grade 2-vs-Grade 3
2.244800E-01
Grade 2-vs-Grade 4
1.595390E-01
Grade 3-vs-Grade 4
3.982000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.073200E-01
Normal-vs-NonDiabetic
4.542600E-01
Diabetic-vs-NonDiabetic
8.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.657760E-01
Normal-vs-NoPancreatitis
5.125800E-01
Pancreatitis-vs-NoPancreatitis
2.649200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.838400E-01
Normal-vs-N1
5.152000E-01
N0-vs-N1
3.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.542000E-03
Normal-vs-TP53-NonMutant
8.650500E-02
TP53-Mutant-vs-TP53-NonMutant
8.702000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
